Users of this system, can login to view this document.

Login

Enter the following information to request a copy of the document from the responsible person.

A Phase I, Open-Label, Dose-Finding Study of GSK2636771, a PI3Kβ Inhibitor, Administered with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer.

This email address is used for sending the document.